Not exact matches
«Precision medicine is already positively affecting providers (for example, by reducing ED visits by 30 % through application of molecular profiling treatment strategy); payers ($ 25 billion expected annual spending on genetic
tests by 2021, and 45 % of FDA approvals were geared toward targeted therapies
in 2013); and pharma (the
pharmacogenomics market is expected to be $ 7.5 billion by 2017).»
This part also refers to the analytical methods used
in pharmacogenomic testing.
This project indicated that not only a vast number of novel potentially functional variants
in a total of 231 pharmacogenes was identified but also demonstrated the value of whole - genome sequencing for
pharmacogenomic testing by capturing over 18,000 variants per individual
in these pharmacogenes.
To address this concern, Molecular Pathology and Pharmacy are collaborating to develop an
in - house
pharmacogenomics testing process to provide an additional clinical tool to strengthen the ability to provide quality patient care.
In the meantime, we are working to develop
pharmacogenomic tests that can help to optimize the benefit to patients of currently available treatments.»
However, despite the major advances
in pharmacogenomics and several commercially available
pharmacogenomics tests, its application
in routine patient care remains very limited.
Proponents of personalized medicine were thankful for several developments that show this trend is picking up speed: CVS followed Medco's example
in expanding
pharmacogenomic testing, while biotech and pharma companies, as well as the National Cancer Institute, stepped up their investment
in the field.
Pharmacogenomics testing Traveled to various offices
in the Atlanta area to perform pharmacy and specimen operations Observe and collect direct urine samples, random and scheduled.